Surgery With or Without Radiofrequency Ablation Followed by Irinotecan in Treating Patients With Colorectal Cancer That is Metastatic to the Liver - Related Studies

Surgery With or Without Radiofrequency Ablation Followed by Irinotecan in Treating Patients With Colorectal Cancer That is Metastatic to the Liver

This study is ongoing, but not recruiting participants.

Study NCT00030563. Last updated on July 23, 2008. Information provided by National Cancer Institute (NCI)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Colorectal Cancer
		Metastatic Cancer

2	Additional conditions recognized in this trial
		Colorectal Neoplasms
		Neoplasm Metastasis

3	More general conditions related to this trial
		Colonic Diseases
		Digestive System Diseases
		Digestive System Neoplasms
		Gastrointestinal Diseases
		Gastrointestinal Neoplasms
		Intestinal Diseases
		Intestinal Neoplasms
		Neoplasms
		Neoplasms by Site
		Neoplastic Processes
		Pathologic Processes
		Rectal Diseases

4	Interventions listed in this trial
		irinotecan hydrochloride
		adjuvant therapy
		conventional surgery
		radiofrequency ablation

5	Additional drug interventions recognized in this trial
		Camptothecin
		Irinotecan

6	More general drug interventions related to this trial
		Antineoplastic Agents
		Antineoplastic Agents, Phytogenic
		Enzyme Inhibitors
		Molecular Mechanisms of Pharmacological Action
		Pharmacologic Actions
		Therapeutic Uses

7	Sponsors listed in this trial
		University of Washington
		National Cancer Institute (NCI)